IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eagle Pharmaceuticals Inc (EGRX)

CUSIP: 269796108 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 572 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Stanley-Laman Group, Ltd.12,000
0.0% of portfolio›$11.4K
Archer Investment Corp350
0.0% of portfolio›$333
StyleTurnoverLocationFiled
Stanley-Laman Group, Ltd.
12,000$11.4K0.0%GrowthMediumBerwyn, PA2026-10-20
Archer Investment Corp
350$3330.0%CoreMediumCarmel, IN2026-11-05